Literature DB >> 19846864

Use of ribavirin to treat influenza.

Kirk M Chan-Tack, Jeffrey S Murray, Debra B Birnkrant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19846864     DOI： 10.1056/NEJMc0905290

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  15 in total

1.  Comparison of ribavirin and oseltamivir in reducing mortality and lung injury in mice infected with mouse adapted A/California/04/2009 (H1N1).

Authors:  Sotirios G Zarogiannis; James W Noah; Asta Jurkuvenaite; Chad Steele; Sadis Matalon; Diana L Noah
Journal:  Life Sci       Date:  2012-01-16       Impact factor: 5.037

Review 2.  Two years after pandemic influenza A/2009/H1N1: what have we learned?

Authors:  Vincent C C Cheng; Kelvin K W To; Herman Tse; Ivan F N Hung; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

Review 3.  How I treat influenza in patients with hematologic malignancies.

Authors:  Corey Casper; Janet Englund; Michael Boeckh
Journal:  Blood       Date:  2009-12-15       Impact factor: 22.113

4.  Gene expression signature-based screening identifies new broadly effective influenza a antivirals.

Authors:  Laurence Josset; Julien Textoris; Béatrice Loriod; Olivier Ferraris; Vincent Moules; Bruno Lina; Catherine N'guyen; Jean-Jacques Diaz; Manuel Rosa-Calatrava
Journal:  PLoS One       Date:  2010-10-04       Impact factor: 3.240

5.  Perspective: emerging challenges in the treatment of influenza and parainfluenza in transplant patients.

Authors:  Ronald B Moss; Roy T Steigbigel; Rebecca L Sanders; Fang Fang
Journal:  Adv Virol       Date:  2011-07-07

Review 6.  Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead.

Authors:  Tony Velkov; Nusaibah Abdul Rahim; Qi Tony Zhou; Hak-Kim Chan; Jian Li
Journal:  Adv Drug Deliv Rev       Date:  2014-11-12       Impact factor: 15.470

Review 7.  Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugs.

Authors:  R Gasparini; D Amicizia; P L Lai; N L Bragazzi; D Panatto
Journal:  J Prev Med Hyg       Date:  2014-09

8.  The Therapeutic Effect of Pamidronate on Lethal Avian Influenza A H7N9 Virus Infected Humanized Mice.

Authors:  Jian Zheng; Wai-Lan Wu; Yinping Liu; Zheng Xiang; Ming Liu; Kwok-Hung Chan; Siu-Ying Lau; Kwok-Tai Lam; Kelvin Kai-Wang To; Jasper Fuk-Woo Chan; Lanjuan Li; Honglin Chen; Yu-Lung Lau; Kwok-Yung Yuen; Wenwei Tu
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

9.  A comprehensive map of the influenza A virus replication cycle.

Authors:  Yukiko Matsuoka; Hiromi Matsumae; Manami Katoh; Amie J Eisfeld; Gabriele Neumann; Takeshi Hase; Samik Ghosh; Jason E Shoemaker; Tiago J S Lopes; Tokiko Watanabe; Shinji Watanabe; Satoshi Fukuyama; Hiroaki Kitano; Yoshihiro Kawaoka
Journal:  BMC Syst Biol       Date:  2013-10-02

10.  Transcriptomic characterization of the novel avian-origin influenza A (H7N9) virus: specific host response and responses intermediate between avian (H5N1 and H7N7) and human (H3N2) viruses and implications for treatment options.

Authors:  Laurence Josset; Hui Zeng; Sara M Kelly; Terrence M Tumpey; Michael G Katze
Journal:  MBio       Date:  2014-02-04       Impact factor: 7.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.